Results 31 to 40 of about 157,236 (308)
von Willebrand disease (VWD), the most common inherited bleeding disorder, is caused by quantitative or qualitative deficiencies in the von Willebrand factor (VWF) protein.
Trinh T. Nguyen, Lakshmi V. Srivaths
semanticscholar +1 more source
Background Mutations of cysteine residues in von Willebrand factor are known to reduce the storage and secretion of this factor, thus leading to reduced antigen levels. However, one cysteine mutation, p.Cys2773Ser, has been found in patients with type 2A(
Jiong-Wei Wang +7 more
doaj +1 more source
PREGNANCY AND DELIVERY IN WOMEN WITH VON WILLEBRAND DISEASE
Given the wide heterogeneity of phenotypes and of the underlying pathophysiological mechanisms associated with the disorder, pregnancy and delivery in von Willebrand disease (VWD) represent a significant clinical challenge.
G. Castaman, P. James
semanticscholar +1 more source
Female case with misdiagnosis of hemophilia A who underwent total knee arthroplasty: A case report
A female was diagnosed with hemophilia A. She had undergone bilateral total knee arthroplasty. She had a history of numerous hemorrhages including hemarthrosis.
Alireza Bari, Hassan Mansouritorghabeh
doaj +1 more source
The diagnosis and treatment of von Willebrand disease (VWD) are challenging, in part because patients exhibit a wide range of bleeding patterns and manifestations (e.g.
F. Peyvandi +4 more
semanticscholar +1 more source
Spontaneous iliopsoas muscle hematoma in a patient with von Willebrand disease: a case report
Introduction Iliopsoas hemorrhage is a serious complication of bleeding disorders that occurs most commonly in patients with hemophilia and less commonly in patients with von Willebrand disease.
Soltani Shirazi Ahmad, Keikhaei Bijan
doaj +1 more source
Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies.
Type 3 von Willebrand disease with alloantibodies is a rare clinical entity with few treatment options. Emicizumab prophylaxis in such patients may result in improved hemarthrosis control, lower cost, and enhanced quality of life.
A. Weyand +3 more
semanticscholar +1 more source
BackgroundAcquired von Willebrand syndrome (AVWS) is a less common bleeding disorder, primarily manifested as mild to moderate mucocutaneous bleeding and laboratory tests are similar to hereditary von Willebrand disease (VWD).
Songmi Wang +6 more
doaj +1 more source
New therapies for von Willebrand disease.
The management of von Willebrand disease (VWD) is based upon the dual correction of the primary hemostasis defect, due to the inherited deficiency of von Willebrand factor (VWF), and of the secondary defect of factor VIII coagulant activity (FVIII:C ...
P. Mannucci
semanticscholar +1 more source
Background: Hemorrhagic events in von Willebrand disease (VWD) impair patients’ physical health, daily functioning, and psychological/emotional well-being.
Annie Borel-Derlon +15 more
doaj +1 more source

